The days are dwindling for the Separate Fact from Fiction webinar series. Click here to check out remaining videos or order and share it with your patients, colleagues, or family. I have been sharing links all week but many missed the time urgency. They only stay available for about 24 hours.
The title above, Science, Patients, and Truth was borrowed from Dr Mark Hyman's interview with Dean Ornish, MD--The Astonishing Power of Lifestyle Medicine. When he lobbied on behalf of nutrition he was asked repeatedly, "Why are you here?", "Who are you working for?" and his answer was--science, patients, and truth.
The title above, Science, Patients, and Truth was borrowed from Dr Mark Hyman's interview with Dean Ornish, MD--The Astonishing Power of Lifestyle Medicine. When he lobbied on behalf of nutrition he was asked repeatedly, "Why are you here?", "Who are you working for?" and his answer was--science, patients, and truth.
I know when I attend the American Association for the Avancement of Sciences (AAAS) meeting next month I will be asked the same questions. I finally have an answer. People blink in wonderment when I tell them I work as a journalist and either find a home for the story after I have written it (outside the influence of a publication or news media), share it on my blog or write a book.
Listen to the podcast below. It does a nice job of summarizing the broader debate in Alzheimer's at least from the pharmaceutical side. An important statistic describes how only about 1 in 10 drugs ever make it to approval. If we are talking about Alzheimer's drugs it has actually been 1 in 244. You read that right. And that single drug? It doesn't stop the progression of the disease.
Listen to the podcast below. It does a nice job of summarizing the broader debate in Alzheimer's at least from the pharmaceutical side. An important statistic describes how only about 1 in 10 drugs ever make it to approval. If we are talking about Alzheimer's drugs it has actually been 1 in 244. You read that right. And that single drug? It doesn't stop the progression of the disease.
The last Alzheimer’s drug approved was in December 2014, and it was a combination of two existing drugs. Before that, a new medicine for Alzheimer’s hadn’t entered the market since 2003. Of the six drugs ever approved to treat Alzheimer’s, none slow its progression.
But that hasn’t stopped drug makers from trying. For the better part of three decades, scientists’ efforts have been focused on beta amyloid — those buildups Dr. Alzheimer saw in his patient’s brain.--The Signal
I don't hear about lifestyle modifcations and the influence of epigenetic and social determinants of health on normal brain health and aging. The data is there. I talk about it all the time. But where is the financial incentive to turn away from desperately trying to prove a well-worn but unproven hypothesis. Careers, money, and time are already in the rabbit hole--ready to catch the cash continually funneled into the pipeline.
There is a lot of hope but you need to put your ear to the ground. Read articles by David Perlmutter, MD and revisit an earlier post, Eat, Love, Meditate to learn about steps you can take today.
There is a lot of hope but you need to put your ear to the ground. Read articles by David Perlmutter, MD and revisit an earlier post, Eat, Love, Meditate to learn about steps you can take today.
It is difficult to get a man to understand something when his salary depends upon his not understanding--Upton Sinclair
Please share, like, and help spread the word...
